Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$116,119,277
+$20,065,473 QoQ
Shares Held
461,450
+4.5% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#231
of 4,153 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allspring Global Investments Holdings, LLC holds $1,085,056,783 across 14 Drug Manufacturers - General names. ABBV ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
314,724 | $377,489,438 | |
| 2 | JNJ |
Johnson & Johnson
|
674,067 | $171,192,794 | |
| 3 | AZN |
Astrazeneca PLC
|
818,235 | $155,153,719 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
461,450 | $116,119,277 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,410,480 | $81,271,856 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
456,141 | $57,628,853 | |
| 7 | MRK |
Merck & Co., Inc.
|
373,604 | $48,008,114 | |
| 8 | AMGN |
Amgen Inc
|
96,472 | $34,934,439 |
All Filings in ABBV
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $116,119,277 | 461,450 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $96,053,804 | 441,647 | Shares | Other | 2026-05-05 | |
| 2025-12-31 | $100,416,327 | 439,478 | Shares | Other | 2026-01-15 | |
| 2025-09-30 | $141,376,934 | 610,594 | Shares | Other | 2025-10-20 | |
| 2025-06-30 | $95,971,850 | 517,034 | Shares | Other | 2025-07-25 | |
| 2025-03-31 | $132,186,377 | 630,901 | Shares | Other | 2025-04-24 | |
| 2024-12-31 | $113,142,299 | 636,704 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $89,604,969 | 453,742 | Shares | Defined | 2024-10-18 | |
| 2024-06-30 | $89,112,185 | 519,544 | Shares | Defined | 2024-07-26 | |
| 2024-03-31 | $93,028,516 | 510,865 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $78,306,030 | 505,298 | Shares | Defined | 2024-01-25 | |
| 2023-09-30 | $59,149,093 | 396,814 | Shares | Defined | 2023-10-27 | |
| 2023-06-30 | $50,793,208 | 377,000 | Shares | Defined | 2023-07-18 | |
| 2023-03-31 | $97,273,868 | 610,365 | Shares | Defined | 2023-04-13 | |
| 2022-12-31 | $122,918,624 | 760,588 | Shares | Defined | 2023-01-23 | |
| 2022-09-30 | $147,905,324 | 1,102,044 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $204,974,793 | 1,338,305 | Shares | Defined | 2022-07-25 | |
| 2022-03-31 | $280,927,874 | 1,732,946 | Shares | Defined | 2022-05-02 | |
| 2021-12-31 | $272,869,046 | 2,015,281 | Shares | Defined | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||